On this page
Neonatal encephalopathy is a clinical syndrome of disturbed neurologic function in the first days after birth, not a single disease or a statement about cause. In term and near-term infants it may involve reduced alertness, seizures, abnormal tone or reflexes, and difficulty initiating or maintaining breathing. Hypoxic-ischemic encephalopathy (HIE) is neonatal encephalopathy attributed to perinatal hypoxia-ischemia; the terms are not interchangeable. This distinction is explicit in the 2026 American Academy of Pediatrics clinical report.
Quick reference
| Topic | Condition-specific guidance |
|---|---|
| What the name means | A time-limited clinical description of abnormal newborn neurologic function |
| Causes | Hypoxia-ischemia is one important cause; infection, stroke or hemorrhage, seizures, metabolic or genetic disease, medication or toxin exposure, and structural conditions are also considered |
| Immediate setting | Urgent neonatal assessment and supportive care, usually in a center able to provide neuromonitoring and neuroimaging |
| Diagnosis | Establish the syndrome, investigate cause, and assess severity; one Apgar score, laboratory value, or image is not sufficient alone |
| Long-term needs | Range from no identified impairment to motor, sensory, cognitive, communication, feeding, or epilepsy-related support |
| Prognosis | Is individualized from cause, serial examinations, EEG, imaging, organ injury, and developmental follow-up |
Recognition and cause
The ACOG–AAP task force defines neonatal encephalopathy in infants born at or beyond 35 weeks as disturbed neurologic function in the earliest days of life, manifested by a subnormal level of consciousness or seizures and often accompanied by difficulty with respiration and depressed tone or reflexes (Neonatal Encephalopathy and Neurologic Outcome). Clinical teams may use related terminology in other gestational-age contexts, but preterm brain injury has additional patterns and differential diagnoses.
Possible causes and contributors include:
- an acute or evolving hypoxic-ischemic event;
- infection or inflammation;
- arterial or venous stroke, intracranial hemorrhage, or other vascular injury;
- neonatal seizures, including genetic epilepsies;
- metabolic, mitochondrial, or other genetic disease;
- congenital brain malformation;
- medication, substance, or toxic exposure; and
- combinations of prenatal, intrapartum, and postnatal factors.
The presence of encephalopathy or receipt of cooling does not by itself prove hypoxia-ischemia. ACOG notes multiple possible causal pathways and discourages assigning an intrapartum cause without the complete clinical evidence (ACOG task-force report).
Acute evaluation and management
This is an urgent neonatal condition. The care team stabilizes breathing, circulation, glucose, temperature, and other physiologic needs while evaluating neurologic function and possible cause. Depending on the presentation, assessment may include:
- pregnancy, labor, delivery, resuscitation, medication, and family history;
- repeated standardized neurologic examinations;
- cord or early blood gases and laboratory assessment for organ dysfunction, infection, and metabolic disease;
- continuous or prolonged EEG because many neonatal seizures have no obvious outward sign;
- brain MRI at clinically appropriate timing, with ultrasound or other imaging when indicated;
- placental examination; and
- targeted infectious, metabolic, genomic, hematologic, or vascular investigation.
An Apgar score describes the newborn's condition and response to resuscitation; it does not predict an individual child's neurologic outcome and should not be used alone to diagnose asphyxia (ACOG: The Apgar Score).
Therapeutic hypothermia applies to a defined HIE subgroup
Cooling is not a general treatment for every cause of neonatal encephalopathy. The 2026 AAP report recommends protocol-based therapeutic hypothermia for eligible newborns with moderate-to-severe HIE, generally born at or beyond 36 weeks, with treatment started as soon as possible within the established time window at a center able to provide neuromonitoring, imaging, and follow-up. Evidence and risk differ for milder HIE, lower gestational ages, or later presentation, so eligibility is a specialist neonatal decision (AAP clinical report).
Other treatment targets the identified cause and complications, such as seizures, infection, metabolic disturbance, organ dysfunction, feeding safety, and respiratory support.
Follow-up and prognosis
No percentage or deterministic prediction applies to the whole syndrome. Outcome varies with cause and severity, gestational age, examination over time, seizure burden and EEG background, MRI pattern, other organ injury, and response to treatment. Mild early signs do not eliminate the need for surveillance, and severe early findings do not define every later ability.
Discharge planning should connect the family with a medical home and risk-appropriate neurology, high-risk infant, hearing, vision, feeding, and developmental follow-up. Evaluation over time may address movement and tone, epilepsy, sleep, vision and hearing, cognition, language, behavior, feeding and swallowing, and participation. Decisions should be updated from the child's observed profile rather than from the neonatal label alone.
Feeding and communication
During neonatal care, communication support begins with helping caregivers read and respond to the infant's behavioral, autonomic, and feeding cues. Feeding readiness and safety depend on respiratory stability, alertness, posture, endurance, and suck–swallow–breathe coordination. Feeding plans should be made with the neonatal and feeding team; coughing, congestion, physiologic instability, poor growth, or difficulty coordinating breathing and swallowing warrants reassessment. See ASHA Pediatric Feeding and Swallowing.
As the child develops, assess hearing, vision, motor access, receptive and expressive communication, interaction, play, and literacy when age appropriate. Some children communicate typically; others benefit from early-intervention language support, partner strategies, signs, pictures, or AAC. AAC should be considered from functional communication needs, not prescribed because of the neonatal diagnosis. See the AAC assessment and acquisition guide and ASHA AAC Practice Portal.
Family communication and care coordination
Families need clear separation of what is known, what is suspected, and what remains uncertain. Useful records include the working cause, treatment received, EEG and imaging summaries, hearing results, feeding plan, emergency seizure instructions when relevant, and scheduled follow-up. Interpreters and accessible formats should be provided when needed. Prognostic conversations should be revisited as evidence accumulates rather than framed as a single prediction at discharge.
Key sources
- American Academy of Pediatrics: Therapeutic Hypothermia for Neonatal HIE (2026)
- ACOG and AAP: Neonatal Encephalopathy and Neurologic Outcome
- ACOG: The Apgar Score
- Canadian Paediatric Society: Hypothermia for Newborns With HIE
- ASHA: Pediatric Feeding and Swallowing
- ASHA: Augmentative and Alternative Communication